Objective: To estimate the effectiveness and safety of triple therapy containing berberine, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori (H. pylori).
Methods: This prospective, randomized controlled, open-label, noninferiority trial included treatment-naive patients with H.